Newsroom

LONDEN--(BUSINESS WIRE)--ITRS, een toonaangevende leverancier van oplossingen voor realtime IT-monitoring en waarneembaarheid voor financiële diensten en gereguleerde sectoren, maakte vandaag bekend dat het bedrijf een definitief akkoord heeft ondertekend om IP-Label over te nemen, een vooraanstaande leverancier van DEM (Digital Experience Monitoring) gevestigd in Frankrijk. Deze overname versterkt de DEM-capaciteiten van ITRS en breidt haar aanwezigheid op de Europese markt aanzienlijk uit. IP...

PARÍS--(BUSINESS WIRE)--Abbelight, líder global y empresa pionera en soluciones integrales de microscopía de superresolución, anunció hoy el cierre exitoso de una ronda de financiación Serie B liderada por AVANT BIO, una firma de capital de crecimiento enfocada en tecnologías de habilitación que están dando forma a las terapias del futuro. “Con una década de experiencia en el mercado de investigación en ciencias de la vida, Abbelight ha estado transformando la manera en que los científicos visu...

TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue, Inc. (NYSE: TBI) (“TrueBlue” or the “Company”) today issued the following statement in response to the comments made by, and nominations from, EHS Management, LLC (“EHS”): TrueBlue is executing a disciplined and decisive plan that is leading to improved financial results, and the Company is well on its way to returning to sustainable, profitable growth. Under our strategic plan, TrueBlue has strengthened performance in attractive end markets, particular...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s Board of Directors approved the grant, effective January 5th, 2026, to three non-executive employees of non-qualified stock...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that Joseph Payne, President & Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, on Monday, January 12, 2026, at 5:15 p.m. Pacific Time. About Arcturus Found...

ロンドン--(BUSINESS WIRE)--（ビジネスワイヤ） -- 金融サービスおよび規制産業向けリアルタイムIT監視・可観測性ソリューションの主要プロバイダーであるITRSは本日、フランスに本社を置くデジタルエクスペリエンス監視（DEM）のトッププロバイダーであるIP-Labelの買収に関する最終契約を締結したことを発表しました。この買収により、ITRSのDEM機能が強化され、欧州市場におけるプレゼンスが大幅に拡大します。 IP-Labelは、AI搭載のEkaraプラットフォームを通じて、25カ国にまたがる310社以上の企業顧客にサービスを提供しています。このプラットフォームは包括的な合成トランザクション監視（STM）、実ユーザー監視（RUM）、AI駆動のインシデントトリアージを提供し、顧客や従業員に影響が及ぶ前にパフォーマンス問題を積極的に特定・解決します。 エカラプラットフォームの独自機能には、複雑なWebアプリケーション、厚いクライアントアプリケーション、ビジネスクリティカルシステム、モバイルアプリケーション、セルフサービスキオスク、仮想デスクトップインフラストラクチャ（...

BURLINGTON, Vermont--(BUSINESS WIRE)--Prolytix, leader américain des services de bioanalyse et de caractérisation des protéines, annonce l'acquisition de 60 tests validés précédemment détenus par Hemostasis Reference Laboratory (HRL). HRL était un laboratoire de référence mondial respecté spécialisé dans les tests de thrombose et d'hémostase. Cette acquisition crée une solution de bout en bout pour les services analytiques de thrombose et d'hémostase. La combinaison de la force fondamentale de...

RICHMOND, Calif.--(BUSINESS WIRE)--City Ventures, California’s leading builder of solar-powered, ecologically responsible homes, has announced the highly anticipated Grand Opening of Parkside at Cherry Blossom Row, an all-electric, solar-powered townhome community located within the East Bay in the Richmond Annex. Pristine, beautifully furnished model homes will open to the public on Saturday, January 10 from 11 am to 2 pm. “Parkside at Cherry Blossom Row’s prime location makes it a standout ch...

LITTLE ROCK, Ark.--(BUSINESS WIRE)--Heartland Renaissance Fund, an affiliate of ACC Capital, receives $85 million in New Markets Tax Credits allocations....

SAN MATEO, Calif.--(BUSINESS WIRE)--Guidewire (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced that it has completed its share repurchase program previously authorized in September 2022 and that, effective immediately, its board of directors has approved a new share repurchase program with authorization to purchase up to $500.0 million of its outstanding shares of common stock. Repurchases under the new program may be made in th...